Arkadios Wealth Advisors Acquires 1,096 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Arkadios Wealth Advisors lifted its stake in HCA Healthcare, Inc. (NYSE:HCA) by 46.9% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,435 shares of the company’s stock after buying an additional 1,096 shares during the quarter. Arkadios Wealth Advisors’ holdings in HCA Healthcare were worth $1,031,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. Terra Nova Asset Management LLC increased its position in HCA Healthcare by 0.3% in the third quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after purchasing an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV grew its stake in HCA Healthcare by 7.4% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares in the last quarter. Waldron Private Wealth LLC raised its position in HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock valued at $683,000 after purchasing an additional 29 shares in the last quarter. Brookstone Capital Management grew its holdings in HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares in the last quarter. Finally, UMB Bank n.a. raised its stake in HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after buying an additional 30 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on HCA shares. Wells Fargo & Company lowered HCA Healthcare from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $400.00 to $320.00 in a research note on Monday, November 25th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Truist Financial decreased their target price on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Oppenheimer lifted their target price on shares of HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Finally, StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $385.27.

HCA Healthcare Stock Up 0.4 %

Shares of NYSE:HCA opened at $310.60 on Monday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a fifty-two week low of $278.50 and a fifty-two week high of $417.14. The stock has a market cap of $78.68 billion, a price-to-earnings ratio of 13.95, a price-to-earnings-growth ratio of 1.03 and a beta of 1.64. The firm’s 50 day moving average price is $316.69 and its 200 day moving average price is $353.01.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 27th. Shareholders of record on Friday, December 13th were paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.85%. The ex-dividend date was Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares in the company, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.